The profile of IL-1β and -6 gene expression in this experimental paradigm was diverging from those of COX-2 and PGE2, since the cytokine tended to be expressed to a higher level in MDD patients at baseline compared to controls, and it was blunted rather than increased by SSRI treatment. Here, IL1B is linked to major depressive disorder.